Ovoca Bio | OVG - Ordinary Share Capital


Ovoca Bio reported EUR29.49M in Ordinary Share Capital for its fiscal semester ending in December of 2025.





Ordinary Share Capital Change Date
Akebia Therapeutics USD 265.42M 199K Dec/2025
Alaunos Therapeutics USD 2.49M 108K Jun/2026
ALKERMES USD 168.03M 489K Sep/2026
Dianthus Therapeutics USD 54.8M 215.59K Jun/2026
Great Western Mining Corporation EUR 231.88M 54.69M Dec/2025
Ionis Pharmaceuticals USD 166.41M 773K Sep/2026
IQVIA Holdings USD 164.8M 200K Sep/2026
Malin Corporation EUR 200K 0 Dec/2024
Moderna USD 391M 2M Sep/2025
Organon & Co USD 262.62M 13K Sep/2026
Ovoca Bio EUR 29.49M 0 Dec/2025
Revvity USD 111.59M 43K Sep/2026
Tectonic Therapeutic USD 19.24M 404.78K Jun/2026
Viatris USD 1.15B 8.79M Sep/2026
Xeris Pharmaceuticals USD 173.59M 1.03M Jun/2026